CTRI/2024/07/070145
Not yet recruiting
未知
Correlation Analysis of Interleukin-1a Levels in Gingival Crevicular Fluid with the Occurrence of External Root Resorption in Patients with Traumatic Dental Injury: A Prospective cohort Study - NI
nithiyalakshmi kanagaraj0 sites0 target enrollmentTBD
Overview
- Phase
- 未知
- Intervention
- Not specified
- Conditions
- Not specified
- Sponsor
- nithiyalakshmi kanagaraj
- Status
- Not yet recruiting
- Last Updated
- last year
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- •Patients of any gender, aged 14 –50 years, with a history of traumatic dental injury
- •(Concussion / Subluxation / Extrusion / Intrusion/ Lateral luxation/ Avulsion)
- •No evidence of caries or periodontal disease during intraoral examination or radiographic
- •examination
- •Systemically healthy patients with a non\-contributory medical history
Exclusion Criteria
- •Patient with a history of Systemic inflammatory conditions or any chronic disease
- •Patients who have taken systemic antibiotics or anti\-inflammatory medications within one
- •month prior to enrollment will be excluded.
- •Patient with primary or secondary acute periodontitis
- •Periodontal probing depth greater than 4mm
Outcomes
Primary Outcomes
Not specified
Similar Trials
Not yet recruiting
Phase 4
A Clinical Trial to test a turmeric based product (Curenext) in treating gum disease.CTRI/2011/05/001767Shaju Jacob P20
Active, not recruiting
Phase 1
Interleukin-1 (IL-1) and Interferon gamma (IFNg) inhibition during COVID 19 inflammation: Randomized, controlled study assessing efficacy and safety of Anakinra and RuxolitinibCovid-19 diseaseTherapeutic area: Diseases [C] - Virus Diseases [C02]EUCTR2020-001963-10-FRCentre Hospitalier Intercommunal de Toulon La Seyne-sur-mer54
Not yet recruiting
Not Applicable
Correlation Of Interleukin-I7A Levels In Blood And Scales With The Severity Of Psoriasis DiseaseHealth Condition 1: L409- Psoriasis, unspecifiedCTRI/2023/08/056432FATHER MULLER MEDICAL COLLEGE
Active, not recruiting
Phase 1
Investigation of the effect of Interleukin-1 receptor antagonist (IL-1ra) on markers of inflammation in non-ST elevation acute coronary syndromes - MRC-ILA-HEART studyWe wish to investigate Acute coronary syndromes (ACS). These are caused by blockages in the main arteries that supply the heart as a result of a process called atherosclerosis. These blockages prevent blood flow down the artery and therefore prevent the heart muscle getting the blood and oxygen that it needs to survive and function. They account for 15% of all deaths in the UK and are associated with considerable long term consequences among survivors.MedDRA version: 8.1 Level: PT Classification code 10051592 Term: Acute coronary syndromeEUCTR2006-001767-31-GBniversity of Sheffield186
Not yet recruiting
Not Applicable
Interleukin gene and its association with survival in Stage IV Lung CancerHealth Condition 1: C349- Malignant neoplasm of unspecifiedpart of bronchus or lungCTRI/2023/10/058696Institute of Medical sciences and SUM Hospital SOA University